Literature DB >> 3825580

Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms.

R Manchanda, R Saupe, S R Hirsch.   

Abstract

A reliability study was carried out to compare the short Manchester Scale (MS) to the longer Brief Psychiatric Rating Scale (BPRS), to see if similar items scored the same aspect of pathology and to find the sources of error. The raters were a psychiatrist and a psychologist cum medical student; they had recently arrived in Britain, came from different cultures and had not used the scale previously. Comparisons between the scales were made by interviewing the patients separately and together using either one or both scales. The items on the MS showed a higher interrater reliability as compared to the BPRS, both with independent and simultaneous ratings. Items based on observation only correlated poorly as compared to items based on verbal report. Lower between-scale correlations for delusions and affect were observed even where the same rater used the two scales, suggesting that the scales have different meanings for these items. The MS is a suitable alternative to the BPRS for quantifying schizophrenic symptoms.

Entities:  

Mesh:

Year:  1986        PMID: 3825580     DOI: 10.1111/j.1600-0447.1986.tb06285.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

1.  Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.

Authors:  Hideaki Tani; Shotaro Takasu; Hiroyuki Uchida; Takefumi Suzuki; Masaru Mimura; Hiroyoshi Takeuchi
Journal:  Neuropsychopharmacology       Date:  2019-11-26       Impact factor: 7.853

2.  Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.

Authors:  Yoshio Yamanouchi; Tsuruhei Sukegawa; Ataru Inagaki; Toshiya Inada; Takashi Yoshio; Reiji Yoshimura; Nakao Iwata
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-11       Impact factor: 5.176

3.  Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia.

Authors:  Jong-Hoon Kim; Seul Lee; Ah-Young Han; Kyungwook Kim; Jinyoung Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-07       Impact factor: 2.570

4.  Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia.

Authors:  Yeon-Jeong Shin; Yo-Han Joo; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-16       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.